14. References
Alexanderson, B.; Evans, D.A.P. and Sjöqvist, F.: Steady-state plasma levels of Nortriptyline in twins: Influence of genetic factors and drug therapy. British Medical Journal 4: 764 (1969).
Åsberg, M.; Cronholm, B.; Sjöqvist, F. and Tuck, D.: Relationship between plasma level and therapeutic effect of nortriptyline. British Medical Journal 3: 331(1971).
Axelrod, J.: Amphetamine: Metabolism, physiological disposition and its effects on catecholamine storage; in Costa and Garattini Amphetamine and Related Compounds, p. 207 (Raven Press, New York 1970).
Axelrod, J.: Noradrenaline: Fate and control of its biosynthesis. Science 173: 598 (1971).
Berger, F.: The relation between the pharmacological properties of meprobamate and the clinical usefulness of the drug; in Efron Psychopharmacology, A Review ofProgress 1957–1967, p. 139–152 (Public Health Service Publication No. 1836, US Government Printing Office (Washington, DC 1960).
Bickel, M.H. and Weder, HJ.: The total fate of a drug: Kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine. Archives Internationale Pharmacodynamie 173:433 (1968).
Blackwell, B.; Marley, E.; Price, J. and Taylor, S.H.: Hypertensive interactions between monoamine oxidase inhibitors and foodstuff. British Journal of Psychiatry 113: 349 (1967).
Brodie, B.B.; Dick, P.; Kielholz, P.; Poeldinger, W. and Theobold, W.: Preliminary pharmacological and clinical results with desmethylimipramine (DMI, G—35020), a metabolite of imipramine. Psychopharmacologia 2: 467 (1961).
Burn, J.H.: Tyramine and other amines as noradrenaline-releasing substances; in Wolstenholme, O’Connor and Vane Adrenergic Mechanisms, p. 326 (Churchill, London 1960).
Clemens, T.L. and Seiemick, S.T.: Psychological method for evaluating medication by repeated exposure to a Stressor film. Diseases of the Nervous System 28: 98–104(1967).
Clinical Psychiatry Committee of the Medical Research Council: Clinical trial of the treatment of depressive illness. British Medical Journal 1:881 (1965).
Corners, C.K.; Rothschild, G.; Eisenberg, L.; Schwartz, L.S. and Robinson, E.: Dextroamphetamine sulphate in children with learning disorders. Archives of General Psychiatry 21:182(1969).
Conney, A.M.: Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews 19: 317–366(1967).
Coppen, A.: Biogenic amines and affective disorders; in Ho and McIsaac Brain Chemistry and Mental Disease, p. 123 (Plenum Press, New York 1971).
Council on Mental Health: Narcotics and Medical Practice. Medical use of morphine and morphine-like drugs and management of persons dependent on them. Journal of the American Medical Association 218: 578(1971).
Davis, J.M.; Bartlett, E. and Termini, B.A.: Overdosage of psychotropic drugs: A review. Diseases of the Nervous System 29: 157–246(1968).
Davis, V.E. and Walsh, M.J.: Alcohol, amines and alkaloids: A possible biochemical basis for alcohol addiction. Science 167:1005(1970).
Dingell, J.V.; Salser, F. and Gillette, J.R.: Species differences in the metabolism of imipramine and desmethylimipramine (DMI); Journal of Pharmacology and Experimental Therapeutics 143: 14 (1964).
Edwards, G.: Comparison of the effects of imipramine and desipramine on some symptoms of depressive illness. British Journal of Psychiatry 111: 889 (1965).
Feighner, J.P.; King, L.J.; Schuckit, M.A.; Croughan, J. and Briscoe, W.: Hormonal potentiation of imipramine and ECT in primary depression. American Journal of Psychiatry 128: 1230(1972).
Fink, M.; Klein, D.F. and Kramer, J.C.: Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders. Psychopharmacologia 7: 27 (1965).
Fish, B.: Problems of diagnosis and the definition of comparable groups: A neglected issue in drug research with children. American Journal of Psychiatry 125: 72 (1969).
Gallant, D.D.; Bishop, M.P.; Guerrero-Figuero, R.; Selby, M. and Phillips, R.: Doxepin versus diazepam. A controlled evaluation in 100 chronic alcholic patients. Journal of Clinical Pharmacology 9: 57 (1969).
General Practitioner Research Group: Oxazepam in anxiety. Practitioner London 799(1191): 356 (1967).
Goldstein, A.: Heroin addiction and the role of methadone in its treatment. Archives of General Psychiatry 26: 291 (1972).
Goldstein, B.J. and Brauzer, B.: Pharmacological considerations in the treatment of anxiety and depression in medical practice. Medical Clinics of North America 55: 485–494 (1971).
Gram, L.F. and Overø, K.F.: Drug interaction: Inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man. British Medical Journal 1: 463(1972).
Greenblatt, M.; Grosser, GM. and Wechsler, H.: Differential response of hospitalized depressed patients to somatic therapy. American Journal of Psychiatry 720: 935 (1964).
Gyermek, L.: The pharmacology of imipramine and related antidepressants. International Reviews of Neurobiology 9: 95 (1966).
Hollister, L.E.: Toxicology of psycho therapeutic drugs; in Clark and del Guidice Principles of Psychopharmacology, p. 537–546 (Academic Press, New York 1970).
Hollister, L.E. and Levy, G.: Kinetics of meprobamate elimination in humans. Chemotherapia 9: 20–24 (1964).
Hollister, L.E.; Motzenbcker, F.P. and Degan, R.O.: Withdrawal reactions from chlordiazepoxide (Librium). Psychopharmacologia 2:63–68 (1961).
Hollister, L.E.; Overall, J.E.; Bennett, J.L.; Kimbell, I. Jr. and Shelton, J.: Specific therapeutic actions of acetophenazine, perphenazine and benzquinamide in newly-admitted schizophrenic patients. Clinical Pharmacology and Therapeutics 8: 249 (1967).
Hollister, L.E.; Overall, J.E.; Johnson, M.; Pennington, V.; Katz, G. and Shelton, J.: Controlled comparison of amitriptyline, imipramine and placebo in hospitalized depressed patients. Journal of Nervous and Mental Diseases 139: 370 (1964).
Hollister, L.E.; Overall, J.E.; Pokomy, A.D. and Shelton, J.: Acetophenazine and diazepam in anxious depressions. Archives of General Psychiatry 24: 273 (1971).
Irwin, S.: Antineurotics: Practical pharmacology of the sedative-hypnotics and minor tranquilizers;in E from Psychopharmacology. A Review of Progress 1957–1967, p. 185–204 (Public Health Service Publication No. 1836, U.S. Government Printing Office, Washington 1968).
Jaffe, J.H. and Senay, EC: Methadone and 1-methadyl acetate. Use in management of narcotics addicts. Journal of the American Medical Association 216: 1303(1971).
Jenner, F.A. and Kerry, R.J.: Comparison of diazepam, chlordiazepoxide and amylobarbitone (a multidose double-blind cross-over study). Diseases of the Nervous System 28: 245 (1967).
Kaim, S.C. and Klett, C.J.: Treatment of delirium tremens. A comparative evaluation of four drugs. Quarterly Journal of Studies in Alcohol (In press, 1972).
Kaim, S.C.; Klett, C.J. and Rothfeld, B.: Treatment of the acute alcohol withdrawal state: A comparison of four drugs. American Journal of Psychiatry 125: 1640–1646(1969).
Kales, A. and Kales, Joyce D.: Sleep laboratory evaluation of psychoactive drugs. Pharmacology for Physicians 4(9): 1–6(1970).
Kaplan, R.; Blume, S.; Rosenberg, S.; Pitrelli, J. and Turner, W.J.: Phenytoin, metronidazole and multivitamins in the treatment of alcoholism. Quarterly Journal of Studies on Alcohol 33: 97 (1972).
Kelly, D.; Brown, C.C. and Shaffer, J.W.: A controlled physiological, clinical and psychological evaluation of chlordiazepoxide. British Journal of Psychiatry 115: 1387(1969).
Klett, C.J.; Hollister, L.E.; Caffey, E.M. Jr. and Kaim, S.C: Evaluating changes in symptoms during acute alcohol withdrawal. Archives of General Psychiatry 24:174(1971).
Lader, M.H. and Wing, L.: Physiological measures, sedative drugs, and morbid anxiety. Maudsley Monograph No.14, p. 1–167 (Oxford University Press, London 1966).
Lasagna, L. and Epstein, K.C.: The use of amphetamines in the treatment of hyperkinetic children; in Costa and Garattini International Symposium on Amphetamines and Related Compounds, p. 849–864 (Raven Press, New York 1970).
Lowenstein, L.; Simone, R.; Boulter, P. and Nathan, P.: Effect of fructose on alcohol concentrations in the blood of man. Journal of the American Medical Association 213: 1889(1970).
Lundwall, L. and Baekeland, F.: Disulfiram treatment of alcoholism. Journal of Nervous and Mental Diseases 755:381(1971).
Maas, J.W.; Farcett, J.A. and Dekirmenjian, H.: Catecholamine metabolism, depressive illness and drug response. Archives of General Psychiatry 26: 252 (1972).
Malitz, S. and Kanzler, M.: Are antidepressants better than placebo? American Journal of Psychiatry 727:1605 (1971).
Martin, W.R.; Sloan, J.W.; Sapira, J.D. and Jasinski, D.R.: Physiologic subjective, and behavioural effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clinical Pharmacology and Therapeutics 12: 245 (1971).
McDonall, A.; Owen, S. and Robin, A.A.: A controlled comparison of diazepam and amylobarbitone in anxiety states. British Journal of Psychiatry 112: 629(1966).
McReynolds, P.: The assessment of anxiety. A survey of available techniques; in Advances in psychological assessment, chapter XIII (Palo Alto, California, Science and Behaviour Books 1968).
Moody, J.P.; Tait, A.C. and Todrick, A.: Plasma levels of imipramine and desmethylimipramine during therapy. British Journal of Psychiatry 113: 183 (1967).
Overall, J.E.; Hollister, L.E.; Johnson, M. and Pennington, V.: Nosology of depression and differential response to drugs. Journal of the American Medical Association 195: 946 (1966a).
Overall, J.E.; Hollister, L.E.; Meyer, F.; Kimbell, I. Jr. and Shelton, J.: Imipramine and thioridazine in depressed and schizophrenic patients. Are there specific antidepressant drugs? Journal of the American Medical Association 189: 605 (1964).
Overall, J.E.; Hollister, L.E.; Pokomy, A.D.; Casey, J.F. and Katz, G.: Drug therapy in depressions. Clinical Pharmacology and Therapeutics 3: 16 (1962).
Overall, J.E.; Hollister, L.E.; Shelton, J.; Johnson, M.M. and Kimbell, I. Jr.: Tranylcypromine compared with dextroamphetamine in hospitalized depressed patients. Diseases of the Nervous System 27: 653 (1966b).
Paykel, E.S.: Classification of depressed patients: A cluster analysis derived grouping. British Journal of Psychiatry 118: 275 (1971).
Pillard, R.C. and Fisher, S.: Effects of chlordiazepoxide and secobarbital on film-induced anxiety. Psychopharmacologia 12: 18 (1967).
Pletscher, A.; Shore, P.A. and Brodie, B.B.: Serotonin as mediator of reserpine action in brain. Journal of Pharmacology and Experimental Therapeutics 116: 84(1956).
Randall, L.O. and Schallek, W.: Pharmacological activity of certain benzodiazepines; in Efron Psychopharmacology — A Review of Progress 1957–1967, p. 153–184 (Public Health Service Publication No. 1836, U.S. Government Printing Office, Washington DC 1968).
Rickeis, K.: Non-specific factors in drug therapy of neurotic patients; in Thomas Non-Specific Factors in Drug Therapy, p. 3–26 (Springfield 1968).
Rickeis, K.; Raab, I.; DeSilverio, R. and Etemad, B.: Drug treatment in depression. Antidepressant or tranquilizer. Journal of the American Medical Association 201: 675 (1967).
Rizzo, M.; Pantarotto, C; Riva, E.; Gianelli, A.; Morselli, P.L. and Garattini, S.: Interactions of tricyclic anti-depressants with other drugs. Fifth International Congress of Pharmacology, San Francisco 1972.
Rubin, E. and Lieber, C.S.: Alcoholism, alcohol and drugs. Science 172:1097(1971).
Sargent, W.: The treatment of depressive states. International Journal of Neurology 6: 53 (1967).
Schildkraut, J.J. and Kety, S.S.: Biogenic amines and emotion. Science 156: 21 (1967).
Schildkraut, J.J.; Schanberg, S.M.; Breese, G.R. and Kopin, I.J.: Norepinephrine metabolism and drugs used in the affective disorders: A possible mechanism of action. American Journal of Psychiatry 124: 54 (1967).
Seevers, M.H.: Morphine and ethanol physical dependence: A critique of a hypothesis. Science 170: 1113 (1970).
Sjöqvist, F.: Interaction between monoamine oxidase (MAO) inhibitors and other substances. Proceedings of the Royal Society of Medicine 58: 967 (1965).
Sjöqvist, F.; Hammer, W.; Borga, O. and Azarnoff, D.L.: Pharmacological significance of the plasma level of monomethylated tricyclic antidepressants; in The Present Status of Psychotropic Drugs. Pharmacological and Clinical Aspects, p.128 (Excerpta Medica Foundation, Amsterdam 1969).
Smith, L.H. Jr. and Becker, C.E.: Medical complications of heroin addiction. California Medicine 115: 42 (1971).
Walter, C.J.S.: Clinical significance of plasma imipramine levels. Proceedings of the Royal Society of Medicine 64: 282 (1971).
Weiss, G.; Werry, J.; Minde, K.; Douglas, V. and Sykes, D.: Studies on the hyperactive child-V. The effects of dextroamphetamine and chlorpromazine on behaviour and intellectual functioning. Journal of Child Psychology and Psychiatry 9: 145 (1968).
Wheatley, D.: Comparative effects of propranolol and chlordiazepoxide in anxiety states. British Journal of Psychiatry 115: 1411 (1969).
Williams, R.B. and Sherter, C.: Cardiac complications of tricyclic antidepressant therapy. Annals of Internal Medicine 74: 395 (1971).
Wilson, J.H.P.; Donker, A.J.M.; Van Der Hem, G.K. and Wientjes, J.: Peritoneal dialysis for lithium poisoning. British Medical Journal 2: 749 (1971). Wittenborn, J.R.; Plante, M.; Burgess, F. and Maurer, H.: A comparison of imipramine, electroconvulsive therapy, and placebo in the treatment of depression. Journal of Nervous and Mental Diseases 135: 131 (1962).
Zeidenberg, P.; Perel, J.M.; Kanzler, M.; Wharton, R.N. and Malitz, S.: Clinical and metabolic studies with imipramine in man. American Journal of Psychiatry 127: 1321 (1971).
Zeller, E.A. and Barsky, J.: In vivo inhibition of liver and brain monoamine oxidase by 1-isonicotinyl-2-isopropylhydrazine. Proceedings of the Society for Experimental Biology and Medicine 81: 459 (1952).
Author information
Authors and Affiliations
Additional information
Second of two parts.
Rights and permissions
About this article
Cite this article
Hollister, L.E. Clinical Use of Psychotherapeutic Drugs II: Antidepressant and Antianxiety Drugs and Special Problems in the Use of Psychotherapeutic Drugs. Drugs 4, 361–410 (1972). https://doi.org/10.2165/00003495-197204050-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197204050-00002